JS']JSH Practical Guidelines for Hematological Malignancies, 2018: I. Leukemia-1. Acute myeloid leukemia (AML)

被引：14

作者：

Kiyoi, Hitoshi ^{[1
]}

Yamaguchi, Hiroki ^{[2
]}

Maeda, Yoshinobu ^{[3
]}

Yamauchi, Takahiro ^{[4
]}

机构：

[1] Nagoya Univ, Dept Hematol & Oncol, Grad Sch Med, Showa Ku, 65 Tsurumai cho, Nagoya, Aichi 4668550, Japan

[2] Nippon Med Sch, Dept Hematol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan

[3] Okayama Univ Hosp, Dept Hematol & Oncol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan

[4] Univ Fukui Hosp, Dept Hematol & Oncol, 23-3 Matsuoka Shimoaizuki, Eiheiji, Fukui 9101193, Japan

来源：

INTERNATIONAL JOURNAL OF HEMATOLOGY | 2020年 / 111卷 / 05期

基金：

日本学术振兴会;

关键词：

GEMTUZUMAB OZOGAMICIN;

D O I：

10.1007/s12185-020-02856-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：595 / 613

页数：19

共 6 条

[1] Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial [J].

Amadori, Sergio ;

Suciu, Stefan ;

Selleslag, Dominik ;

Aversa, Franco ;

Gaidano, Gianluca ;

Musso, Maurizio ;

Annino, Luciana ;

Venditti, Adriano ;

Voso, Maria Teresa ;

Mazzone, Carla ;

Magro, Domenico ;

De Fabritiis, Paolo ;

Muus, Petra ;

Alimena, Giuliana ;

Mancini, Marco ;

Hagemeijer, Anne ;

Paoloni, Francesca ;

Vignetti, Marco ;

Fazi, Paola ;

Meert, Liv ;

Ramadan, Safaa Mahmoud ;

Willemze, Roel ;

de Witte, Theo ;

Baron, Frederic .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (09) :972-+

[2]

Bross PF, 2001, CLIN CANCER RES, V7, P1490

[3] Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study [J].

Castaigne, Sylvie ;

Pautas, Cecile ;

Terre, Christine ;

Raffoux, Emmanuel ;

Bordessoule, Dominique ;

Bastie, Jean-Noel ;

Legrand, Ollivier ;

Thomas, Xavier ;

Turlure, Pascal ;

Reman, Oumedaly ;

de Revel, Thierry ;

Gastaud, Lauris ;

de Gunzburg, Noemie ;

Contentin, Nathalie ;

Henry, Estelle ;

Marolleau, Jean-Pierre ;

Aljijakli, Ahmad ;

Rousselot, Philippe ;

Fenaux, Pierre ;

Preudhomme, Claude ;

Chevret, Sylvie ;

Dombret, Herve .

LANCET, 2012, 379 (9825) :1508-1516

[4] Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia: final results of Japanese multicenter cooperative study [J].

Kobayashi, Yukio ;

Tobinai, Kensei ;

Takeshita, Akihiro ;

Naito, Kensuke ;

Asai, Osamu ;

Dobashi, Nobuaki ;

Furusawa, Shinpei ;

Saito, Kenji ;

Mitani, Kinuko ;

Morishima, Yasuo ;

Ogura, Michinori ;

Yoshiba, Fumiaki ;

Hotta, Tomomitsu ;

Bessho, Masami ;

Matsuda, Shin ;

Takeuchi, Jin ;

Miyawaki, Shuichi ;

Naoe, Tomoki ;

Usui, Noriko ;

Ohno, Ryuzo .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (04) :460-469

[5] Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence [J].

Larson, RA ;

Sievers, EL ;

Stadtmauer, EA ;

Löwenberg, B ;

Estey, EH ;

Dombret, H ;

Theobald, M ;

Voliotis, D ;

Bennett, JM ;

Richie, M ;

Leopold, LH ;

Berger, MS ;

Sherman, ML ;

Loken, MR ;

van Dongen, JJM ;

Bernstein, ID ;

Appelbaum, FR .

CANCER, 2005, 104 (07) :1442-1452

[6] A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia [J].

Petersdorf, Stephen H. ;

Kopecky, Kenneth J. ;

Slovak, Marilyn ;

Willman, Cheryl ;

Nevill, Thomas ;

Brandwein, Joseph ;

Larson, Richard A. ;

Erba, Harry P. ;

Stiff, Patrick J. ;

Stuart, Robert K. ;

Walter, Roland B. ;

Tallman, Martin S. ;

Stenke, Leif ;

Appelbaum, Frederick R. .

BLOOD, 2013, 121 (24) :4854-4860

← 1 →